Akums Drugs and Pharmaceuticals Ltd

Akums Drugs and Pharmaceuticals Limited trading window closed from 1st October, 2026 till 48 hrs. after the declaration of un-audited (Standalone & Consolidated) Financial Results for the quarter ending 30th September, 2026.

Meeting Details

• Event: Institutional Investor Meeting.
• Dates/times: 28 Sep 2026, 09:00 IST onwards; Mumbai physical.
• Meet type and mode: Multiple one-on-one & group meetings.
• Dates/times: 29 Sep 2026, 09:00 IST onwards; Mumbai physical.

Participants

• Key participant: Company Secretary & Compliance Officer from Akums.

Purpose

• Purpose: Institutional investor meets for investor interaction.

Additional Notes

• Disclosure to be updated on company website.

Meeting Details

• Date and time: 22 September 2026, starts at 10:00 AM IST
• Type/Mode: Group meet, physical
• Event/Organizer: G200 Summit 2026
• Location: Taj, Santacruz, Mumbai
• Purpose: Investor/analyst interaction
• Key company participant: Company Secretary & Compliance Officer

ESG rating disclosure

• ESG rating of 65 for FY 2025-26 issued by NSE Sustainability Ratings & Analytics.
• Company states it did not engage the rating provider; rating based on publicly available information.

Meeting Details

• Date & time: 2 September 2026, 02:00 PM IST
• Type and mode: Group meet, physical at Hyatt Santacruz East, Mumbai

Participants

• Key company participants: Company Secretary & Compliance Officer

Purpose

• Purpose: investor/analyst meet to discuss company updates

Meeting Details

• Meeting date: August 25, 2026; physical investor/analyst meet at Trident, Mumbai.
• Company participation cancelled due to medical reasons.

Meeting Details

• Date and time: 25 August 2026, 09:00 AM IST.
• Type/Mode: Group meet, physical.
• Event: Antique Healthcare Investor Conference.

Participants

• Key company participants: not specified.

Purpose

• Purpose: investor/analyst meeting with Akums.

Additional Notes

• Disclosure updated on the company's website.

Meeting Details

• Date and time: August 10, 2026 at 12:00 IST.
• Type and mode: group investor conference call.
• Event/organiser: 1QFY27 earnings conference call hosted by Ambit Capital.
• Key company participants: MDs, CFO, Head Strategy, Head Investor Relations.
• Purpose: discussion of unaudited Q1 FY27 results.
• Recording: conference call was recorded; transcript may be available.
• Transcript availability: transcript on the company website.

Meeting Details

• Date & time: 14 August 2026, 09:00 IST.
• Type & mode: Group meet, physical.
• Event: Emkay Confluence 2026 – India: Full Throttle Ahead.
• Venue: Grand Hyatt, Mumbai.
• Company participants: not specified.
• Purpose: investor/analyst interaction.

Meeting Details

• Date and time: August 10, 2026 at 12:00 PM IST.
• Type and mode: Group conference call (virtual).
• Event/organiser: Investors/Analysts Conference Call for Q1 FY27 results.
• Key company participants: not specified.
• Purpose: Discuss un-audited Q1 FY27 results for quarter ended June 30, 2026.
• Availability: Audio recording released; transcript to be shared with exchanges and uploaded on website.